This situation has been going on for too long, in which the FDA is doing everything to preserve the market of large pharmaceutical companies and the established method of treatment and diagnosis. They have already refused to validate the drug once. Even this time, I would not be surprised if they ask for additional information and new analyzes and simply refuse to validate the drug. In any case, the FDA has no obligation to the committee that voted. I think today it will be clearer in which direction ARDELUX is going, I expect a big fall or jump in shares.$Ardelyx(ARDX)$
We will find out in less than 1 hour.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments